Latest Myeloma News

Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myeloma

Elotuzumab (Empliciti) failed for a third time to improve progression-free survival (PFS)

Derick Alison Derick Alison

Pulled Myeloma Drug May Have a Role in Treating the Disease After All

A little more than a year after belantamab mafodotin (Blenrep), an anti-B-cell

Derick Alison Derick Alison

Quad Regimen for High-Risk Myeloma Produces High Rates of Durable MRD Negativity

A four-drug regimen for newly diagnosed high-risk multiple myeloma induced high rates

Derick Alison Derick Alison

IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma

Use of intravenous immunoglobulin (IVIg) may substantially reduce the risk for severe

Derick Alison Derick Alison